About SURGE Therapeutics
SURGE Therapeutics is a private company based in Cambridge, Massachusetts. It has reported $52,638,412 raised in two offerings on Form D since December 2020. Its chief executive is Michael Goldberg.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 19, 2023 | Jun 2, 2023 | $32,003,969of $49.9M target | 22 | $1.4M | EquityRule 506(b) | Form D ↗ |
| Nov 23, 2020 | Dec 4, 2020 | $20,634,443of $29.6M target | 5 | $4.1M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $52,638,412 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on SURGE Therapeutics's Form D filed Jun 2, 2023.
GG
Gary Goldberg
Director
MG
Michael Goldberg
President and Chief Executive Officer, director
JC
Jason Coloma
Director
CC
Chuck Carignan
Executive officer
AG
Antonio Gualberto
Executive officer
KH
Kouki Harasaki
Director
AF
Ali Farahanchi
Director